Article ID Journal Published Year Pages File Type
2971843 The Journal of Heart and Lung Transplantation 2010 8 Pages PDF
Abstract
Lipopolysaccharide pre-treatment reduced lung injury and inflammatory mediator production after subsequent exposure to ischemia-reperfusion. Understanding the clinical significance of lipopolysaccharide in donor lungs has the potential to expand and clarify donor inclusion criteria.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury
Authors
, , , , ,